SS

Shital Sandip Tawari

Director Director DIN 09657733
DIN 09657733 First appointment Jun 2022 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Shital Sandip Tawari

Data last updated:

Shital Sandip Tawari was a Director at Dosage Life Sciences Private Limited (2022–2024). The company operates in Food And Beverages.

DIN 09657733
Primary Designation Director
Industry Food And Beverages
First Appointment 29 Jun 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dosage Life Sciences Private Limited U24306HR2022PTC104816
Director29 Jun 20222022₹11.6 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dosage Life Sciences Private Limited
Premium access

Shareholding and investment profile for Shital Sandip Tawari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shital Sandip Tawari

Shital Sandip Tawari was first appointed on 29 Jun 2022 as Director at Dosage Life Sciences Private Limited.

Shital Sandip Tawari held 1 earlier board appointment: Dosage Life Sciences Private Limited (Director, 29 Jun 2022 to 07 Dec 2024).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available